Identification of an Immunogenic Medulloblastoma-Specific Fusion Involving <i>EPC2</i> and <i>GULP1</i>
Medulloblastoma is the most common malignant brain tumor in children. Immunotherapy is yet to demonstrate dramatic results in medulloblastoma, one reason being the low rate of mutations creating new antigens in this entity. In tumors with low mutational burden, gene fusions may represent a source of...
Enregistré dans:
Auteurs principaux: | Claudia Paret, Nadine Lehmann, Hannah Bender, Maximilian Sprang, Clemens J. Sommer, Denis Cana, Larissa Seidmann, Arthur Wingerter, Marie A. Neu, Khalifa El Malki, Francesca Alt, Lea Roth, Federico Marini, Malte Ottenhausen, Martin Glaser, Markus Knuf, Alexandra Russo, Joerg Faber |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ef2a8eb1cda543319a2d2d59080d5609 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
DEFINITION OF THE FIELDS OF THE BEST PRACTICES OF EPC (M)-PROJECT MANAGEMENT ON THE BASIS OF THE ANALYSIS OF THE WORLD MARKET
par: A. Laznik
Publié: (2017) -
The impact of magnetic resonance imaging spectroscopy parameters on differentiating between paediatric medulloblastoma and ependymoma
par: Nguyen Minh Duc
Publié: (2021) -
Immunotherapy in Medulloblastoma: Current State of Research, Challenges, and Future Perspectives
par: Marije J. Voskamp, et autres
Publié: (2021) -
The SERL Observatory Dataset: Longitudinal Smart Meter Electricity and Gas Data, Survey, EPC and Climate Data for over 13,000 Households in Great Britain
par: Ellen Webborn, et autres
Publié: (2021) -
ONC201/TIC10 Is Empowered by 2-Deoxyglucose and Causes Metabolic Reprogramming in Medulloblastoma Cells in Vitro Independent of C-Myc Expression
par: Annika Dwucet, et autres
Publié: (2021)